PMS2 and neoplasm: (26) reported that single PMS2-deficient CRC displayed a higher tumor stage, lower CD3+ T-cell infiltration, and a trend towards fewer mutations in B2M; it may resemble pMMR CRC with regards to tumor initiation and early evolution.